I’m back from the ASCO Meeting in Chicago. As promised, I’ll try to post some photos tomorrow to give you a sense of just how monumentally huge this meeting is. I probably won’t have time to blog about the clinical science presented until Friday or next week, but we’ll see. In the meantime, let me […]
I haven’t yet mentioned it, but since Friday evening I’ve been in Chicago for the American Society of Clinical Oncology meeting. (If anyone happens to be attending the meeting and is interested in a meetup, let me know. My time’s pretty well booked until I leave on Tuesday afternoon, but we might be able to […]
Abel Pharmboy shows why I shouldn’t have left my American Society of Clinical Oncology (ASCO) proceedings abstract sit on my desk unread for a week. Damn. Talk about blowing an opportunity. Of course, given that I don’t own any pharmaceutical stocks (making me a rather poor “tool of big pharma” indeed), it doesn’t matter.
This week has been a bit of a rough and depressing week on the old blog, with the news that Battlestar Galactica will probably be entering its last season,the appearance of annoying conspiracy theorists in new posts and trolls in old posts, really irritating technical difficulties the ScienceBlogs site, and the need to debunk two […]
I don’t often do this, but every so often I come across a question that I need help deciding. What’s the use of having a moderately popular blog (alas, 3,000 visits a day do not constitute an “immensely popular” blog) if I can’t sometimes use it for my own nefarious purposes, right? The question is […]
